Washington is throwing its weight behind a new mosquito-fighting gadget that does not need a plug, a battery or even much attention once it is hung up. The U.S. State Department, SC Johnson and the Global Fund have launched a three-year push to scale up an American-developed spatial repellent called Guardian, a program officials say could help protect roughly 60 million people in high-risk countries from malaria. The small device hangs inside homes and community buildings, works without electricity and, in field studies, has been shown to cut mosquito biting for as long as a year.
The partnership plans to introduce Guardian in about 10 priority countries and fast-track large-scale distribution through the Global Fund’s procurement and delivery platform, with a target of reaching tens of millions of people over three years, according to a press release from SC Johnson on PR Newswire. Officials are pitching the rollout as part of an innovation drive that uses the State Department’s America First Global Health Strategy funding to push the product quickly into real-world settings.
Manufacturing and scale
SC Johnson says it has already spun up the hardware to match the rhetoric. The company opened high-speed manufacturing lines in Nairobi last year that are capable of producing up to 20 million Guardian units a year, and it reports heavy investment in both product development and local production capacity. The program is described as not-for-profit, with more than $120 million committed to develop, test and manufacture the technology for public health use, according to SC Johnson.
Evidence and WHO backing
The case for Guardian rests on data that mosquito experts pay attention to. In one experimental-hut trial in Tanzania, continuous Guardian use was associated with an estimated 82.7 percent reduction in mosquito blood-feeding and about a 65 percent drop in mosquito landings over 12 months.
The World Health Organization in August 2025 issued a conditional recommendation for spatial emanators and has prequalified both Guardian and a one-month product called Mosquito Shield, opening the door for international procurement, according to the World Health Organization. Related trial results and product summaries have also appeared in the journal Frontiers in Malaria.
What this could change
Malaria still kills more than 600,000 people every year, most of them young children, and global progress has hit a stubborn plateau. Supporters of Guardian argue it can help plug some of the protection gaps that have emerged, especially during daytime and early evening hours when bed nets are not much help and people are cooking, working or socializing.
The pitch is not to replace existing tools but to stack another layer of defense on top of them. Advocates say that adding a year-long, passive repellent to current approaches could help reduce transmission in areas where mosquito resistance and shifting mosquito behavior have blunted earlier gains, a point that featured heavily in the launch messaging. The approach is described as deliberately complementary to bed nets and other interventions, according to PR Newswire and partner statements.
How the rollout will work
Under the plan, the State Department will route financing through the Global Fund so that national ministries of health can procure Guardian and fold it into their existing malaria and vector control programs. Priority will go to countries in sub-Saharan Africa and parts of Southeast Asia where malaria remains entrenched.
Spokespeople for the department and the Global Fund, quoted in early coverage, framed the move as a way to pair U.S. innovation with an already scaled delivery system so products can show up faster in villages and neighborhoods rather than sitting in a policy brief, as reported by the Tampa Free Press.
Limits and next steps
Experts are quick to note that spatial emanators are not a cure-all. WHO and independent researchers highlight significant evidence gaps, including how well these products work on their own, what kind of protection they offer outdoors and how they might function in emergency or displacement settings. They also stress the need for close monitoring as countries start to adopt the tool.
Ongoing trials and implementation studies are expected to clarify which delivery models work best, how often devices should be replaced and how Guardian should be layered with bed nets and indoor spraying. Those questions are being probed in recent research and product summaries in Frontiers, alongside company materials from SC Johnson.
